Dextran coated bismuth-iron oxide nanohybrid contrast agents for computed tomography and magnetic resonance imaging.
about
In vivo delivery, pharmacokinetics, biodistribution and toxicity of iron oxide nanoparticlesGold silver alloy nanoparticles (GSAN): an imaging probe for breast cancer screening with dual-energy mammography or computed tomography.Lipoproteins and lipoprotein mimetics for imaging and drug delivery.Magnetite nanoparticles for cancer diagnosis, treatment, and treatment monitoring: recent advances.Magnetic and fluorescent carbon-based nanohybrids for multi-modal imaging and magnetic field/NIR light responsive drug carriers.Opportunities for new CT contrast agents to maximize the diagnostic potential of emerging spectral CT technologies.Use of Nanoparticle Contrast Agents for Cell Tracking with Computed Tomography.Improved sensitivity of computed tomography towards iodine and gold nanoparticle contrast agents via iterative reconstruction methods.Nanocatalysts promote Streptococcus mutans biofilm matrix degradation and enhance bacterial killing to suppress dental caries in vivoDual-Functional Dextran-PEG Hydrogel as an Antimicrobial Biomedical Material.Synthesis, Functionalization, and Design of Magnetic Nanoparticles for Theranostic Applications.An update on nanoparticle-based contrast agents in medical imaging.Toxicology of Engineered Nanoparticles: Focus on Poly(amidoamine) Dendrimers.Recent advances and future prospects of iron oxide nanoparticles in biomedicine and diagnostics.Advantages and Limitations of Current Techniques for Analyzing the Biodistribution of NanoparticlesFacile synthesis of magnetic core–shell nanocomposites for MRI and CT bimodal imagingAssessment of candidate elements for development of spectral photon-counting CT specific contrast agentsDeveloping Mn-doped lead sulfide quantum dots for MRI labels
P2860
Q36289257-E99BE740-A6E8-405B-9D08-57EF4B96C752Q37114007-E1CD02EE-9F50-4415-9BF0-2DCE774B7611Q38822339-91A47357-AA2D-4064-8C00-7806142906C0Q38831346-A7B01669-348D-4760-9F85-58DCC2A437FDQ38835517-DC357D9C-2F35-48E3-BC97-28C4E951A477Q38952613-189F99E3-1734-44D8-AAA4-FC77BE1B1C17Q39293573-20C16F1F-0C2D-4C8E-960D-104EF3C2C94EQ41840106-9BBCFDA2-9A73-4EF9-97EC-916E14DFB231Q42413982-1F710D1C-5FCB-4891-A6BB-D60B1FB95FA9Q47295606-040E70C4-47E1-480E-8971-7D0458C069CBQ47589446-FA5E8432-B30E-430A-AA29-EAB761EFBE1FQ48654705-AFE55123-43EE-4C35-97B6-13889493214EQ50002187-834CFFC5-5106-4855-8AA1-0FAEE6349397Q55001915-ED56C6E5-E195-4650-8C4D-011ACCF9F416Q57181636-9B882CA3-AD88-4A5E-BE69-63AE0E794BBBQ57578642-334E1FF6-6741-4D33-852B-2CD68AC77430Q58783143-A0D2894D-7D45-4FE0-861A-C8FA3FDEBA91Q59100853-91F24218-131B-4CF4-AE64-477E67BB2D9B
P2860
Dextran coated bismuth-iron oxide nanohybrid contrast agents for computed tomography and magnetic resonance imaging.
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Dextran coated bismuth-iron ox ...... nd magnetic resonance imaging.
@ast
Dextran coated bismuth-iron ox ...... nd magnetic resonance imaging.
@en
Dextran coated bismuth-iron ox ...... nd magnetic resonance imaging.
@nl
type
label
Dextran coated bismuth-iron ox ...... nd magnetic resonance imaging.
@ast
Dextran coated bismuth-iron ox ...... nd magnetic resonance imaging.
@en
Dextran coated bismuth-iron ox ...... nd magnetic resonance imaging.
@nl
prefLabel
Dextran coated bismuth-iron ox ...... nd magnetic resonance imaging.
@ast
Dextran coated bismuth-iron ox ...... nd magnetic resonance imaging.
@en
Dextran coated bismuth-iron ox ...... nd magnetic resonance imaging.
@nl
P2093
P2860
P356
P1476
Dextran coated bismuth-iron ox ...... nd magnetic resonance imaging.
@en
P2093
Ajlan Al Zaki
Andrew Tsourkas
Douglas M Yates
Elizabeth Hecht
Eric Blankemeyer
Harold I Litt
Michael Chorny
Peter Chhour
Walter R T Witschey
P2860
P304
P356
10.1039/C4TB01159G
P407
P577
2014-12-01T00:00:00Z